Country: Australia
Bahasa: Inggeris
Sumber: Department of Health (Therapeutic Goods Administration)
Imipramine hydrochloride
Link Medical Products Pty Ltd T/A Link Pharmaceuticals
Medicine Registered
Version 4.0 1 TOFRANIL ® _Imipramine hydrochloride _ CONSUMER MEDICINE INFORMATION _ _ _Name _ _Address _ _Address _ WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Tofranil. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. The information in this leaflet was last updated on the date listed on the final page. More recent information on the medicine may be available. YOU SHOULD ENSURE THAT YOU SPEAK TO YOUR PHARMACIST OR DOCTOR TO OBTAIN THE MOST UP TO DATE INFORMATION ON THE MEDICINE. Those updates may contain important information about the medicine and its use of which you should be aware. All medicines have risks and benefits. Your doctor has weighed the risks of you or your child taking this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT TOFRANIL IS USED FOR Tofranil is used to treat: 1. Depression that is longer lasting and/or more severe than the "low moods" that everyone has from time to time due to the stress of everyday life. It is thought to be caused by a chemical imbalance in parts of the brain. This imbalance affects your whole body and can cause emotional and physical symptoms such as feeling low in spirit, loss of interest in activities, being unable to enjoy life, poor appetite or overeating, disturbed sleep, loss of sex drive, lack of energy and feeling guilty over nothing. 2. Bed-wetting in people from the age of 5 years onwards if there is no physical cause for the problem (i.e. there is nothing Baca dokumen lengkap
Version 4.0 1 PRODUCT INFORMATION TOFRANIL ® (IMIPRAMINE HYDROCHLORIDE) NAME OF MEDICINE Imipramine hydrochloride Chemical structure: N N(CH 3 ) 2 . HCl Empirical formula: C 19 H 24 N 2 . HCl Molecular weight: 316.9 CAS No: 113-52-0 DESCRIPTION 5-(3-Dimethylamino-propyl)-10, 11-dihydro-5H-dibenz[b,f]azepine hydrochloride (imipramine hydrochloride). Imipramine hydrochloride is a white to yellowish powder. It is freely soluble in water, methanol, and ethanol; soluble in acetone; slightly soluble in ethyl acetate; and practically insoluble in ether and petroleum ether. Tofranil tablets contain either 10 mg or 25 mg of the active drug, imipramine hydrochloride as well as the excipients: Silica - colloidal anhydrous, glycerol, lactose, magnesium stearate, starch-maize, stearic acid, - talc-purified, hypromellose, povidone, titanium dioxide, cellulose - microcrystalline, macrogol 8000, sucrose, iron oxide red (CI No. 77491), printing ink Opacode S-1-7020 (White) (Tofranil 10 mg tablets only), carnauba wax (Tofranil 25 mg tablet only) and the printing ink InterWhite 2200A (Tofranil 25mg tablet only). PHARMACOLOGY PHARMACODYNAMICS Imipramine is a tricyclic antidepressant with a multivalent spectrum of pharmacological action, which includes alpha-adrenolytic, anti-histaminic, anticholinergic, and 5-HT-receptor blocking properties. However, the therapeutic activity of imipramine is believed to be based mainly on its ability to inhibit the neuronal re-uptake of noradrenaline (NA) and serotonin (5-HT). Imipramine belongs to the category of so-called "mixed" re-uptake blockers, i.e. it has been shown to inhibit the re-uptake of NA and 5-HT to approximately the same extent in the rat brain. PHARMACOKINETICS ABSORPTION: Version 4.0 2 Imipramine is Baca dokumen lengkap